Core Viewpoint - The company has announced an extension of the completion date for its fundraising investment project, the "Yifeng Digital Platform Upgrade Project," from July 31, 2025, to December 31, 2025, without changing the project implementation subject, method, total investment amount, or purpose [2][5][6]. Fundraising Basic Information - The company issued 17,974,320 convertible bonds at a face value of RMB 100 each, raising a total of RMB 1,797.432 million. After deducting underwriting and sponsorship fees, the net amount raised was RMB 1,780.932 million [3][4]. Fundraising Usage Status - As of June 30, 2025, the company has invested RMB 73.621 million in the "Yifeng Digital Platform Upgrade Project," achieving an investment progress of 91.29% against a planned total investment of RMB 80.642 million [4]. Reasons for Project Delay - The delay in the "Digital Project" is due to the complexity of integrating multiple systems (product, logistics, finance, and human resources), which has led to challenges in platform integration and promotion. Additionally, some expenses related to personnel salaries and social insurance cannot be paid directly from the fundraising account, necessitating the use of self-owned funds initially [5][6]. Impact of Project Delay - The project delay is a prudent decision based on the actual implementation situation and will not adversely affect the company's normal operations or harm the interests of shareholders, particularly minority shareholders. The decision aligns with the company's long-term development plan [6][8]. Review Procedures and Opinions - The board of directors and the supervisory board approved the extension of the project completion date during meetings held on July 30, 2025. The supervisory board expressed agreement with the decision, confirming compliance with relevant laws and regulations [7][8][9].

Core Points - The board of directors of Yifeng Pharmacy held its 19th meeting of the 5th session on July 30, 2025, with all 9 directors present, and the meeting was conducted in accordance with legal and regulatory requirements [1][4] - The board approved several key proposals, including the cancellation of the supervisory board and amendments to the company's articles of association, which will be submitted for shareholder approval [2][5] - The board also approved the extension of the completion date for the "Yifeng Digital Platform Upgrade Project" from July 31, 2025, to December 31, 2025, without changing the project implementation subject, method, total amount of raised funds, or purpose [3][4] - A proposal was made to use up to 7.05 million yuan of the company's own funds to cover certain costs related to the digital platform upgrade project, with plans to replace these funds with equivalent amounts from the raised funds [3][4] - The company will hold its second extraordinary general meeting of 2025 on August 25, 2025, at 14:30, in Changsha, Hunan Province, with the board authorized to handle related matters [5]

Core Viewpoint - The company plans to use its own funds to pay part of the expenses for the "Digital Platform Upgrade Project" and subsequently replace these with raised funds, amounting to no more than 7.05 million yuan [1][4]. Fundraising Basic Situation - The company issued 17,974,320 convertible bonds at a face value of 100 yuan each, raising a total of 1.797 billion yuan, with net proceeds after deducting issuance costs amounting to 1.327 billion yuan [1][2]. Investment Project Basic Situation - As of June 30, 2025, the total investment for the projects is 2.534 billion yuan, with 1.797 billion yuan planned to be funded by the raised funds, and 443.06 million yuan already utilized [2][3]. Reasons for Using Own Funds - The company needs to use its own funds for salary and social insurance payments during the project implementation, as these payments must be processed through the company's basic deposit account [3][4]. Impact on the Company - The use of self-funds followed by replacement with raised funds is expected to enhance the efficiency of fund utilization and overall operational management, ensuring the smooth progress of the investment project [4][5]. Review Procedures and Opinions - The board and supervisory committee approved the proposal to use self-funds for the project, confirming that this does not harm the interests of the company or its shareholders and complies with relevant regulations [5][6].

Core Viewpoint - The company has announced an extension of the completion date for its fundraising investment project, the "Digital Platform Upgrade Project," from July 31, 2025, to December 31, 2025, without changing the project implementation subject, method, total investment, or use of funds [1][4]. Fundraising Basic Information - The company issued 17,974,320 convertible bonds at a face value of RMB 100 each, raising a total of RMB 1.797 billion, with net proceeds after deducting issuance costs amounting to RMB 1.793 billion [1][2]. Fundraising Usage Status - As of June 30, 2025, the total investment for the "Digital Platform Upgrade Project" is RMB 80.642 million, with RMB 73.621 million already invested, representing a progress rate of 91.29% [2][3]. Reasons for Project Delay - The delay in the "Digital Project" is attributed to the complexity of integrating multiple systems (product, logistics, finance, and human resources), which has led to challenges in platform integration and promotion [3][4]. Impact of Project Delay - The project delay is a cautious decision based on actual implementation conditions and will not adversely affect the company's normal operations or harm the interests of shareholders, particularly minority shareholders [4][5]. Review Procedures and Opinions - The board of directors and the supervisory board approved the extension of the project completion date during meetings held on July 30, 2025, confirming that the decision complies with relevant laws and regulations [4][5].

Group 1 - The core viewpoint of the article is that Yifeng Pharmacy has decided to extend the completion date of its digitalization project from July 31, 2025, to December 31, 2025, due to the complexity and interconnectivity of the systems involved [5][6]. - The total investment for the digitalization project is 80.642 million yuan, with the company planning to use the same amount from the raised funds [3]. - As of June 30, 2025, the company has invested 73.621 million yuan in the digitalization project, achieving a progress rate of 91.29% [3]. Group 2 - The delay in the project is attributed to the challenges in integrating various systems such as product, logistics, finance, and human resources, which has led to a postponement in platform integration and promotion [4]. - The company has confirmed that the extension will not change the project implementation entity, method, total investment amount, or usage of the raised funds, ensuring that it aligns with the long-term development plan and interests of shareholders [5][6]. - The board of directors and the supervisory board have approved the extension, affirming that the decision complies with relevant laws and regulations [6].

Core Viewpoint - The company intends to use its own funds to pay for part of the investment project and subsequently replace it with raised funds, which is in compliance with regulatory requirements and aims to enhance the efficiency of fund utilization [1][5]. Fundraising Basic Situation - The company has received approval from the China Securities Regulatory Commission to issue convertible bonds, with net fundraising amounting to approximately 253.43 million yuan after deducting related expenses [1][2]. Investment Project Basic Situation - As of June 30, 2025, the total investment for the projects, including the Jiangsu Phase II, Hubei Pharmaceutical Sorting and Processing Center, and Hebei Pharmaceutical Warehouse, amounts to 253.43 million yuan, with 179.74 million yuan allocated from the raised funds [2]. Reasons for Using Own Funds - The company faces challenges in using raised funds directly for certain expenses, such as employee salaries and social insurance, which must be paid through the basic deposit account. Therefore, it plans to use up to 7.05 million yuan of its own funds for these payments and later replace them with raised funds [3][4]. Impact on the Company - The use of self-funds for project payments and subsequent replacement with raised funds is expected to improve fund utilization efficiency and ensure the smooth progress of investment projects without affecting the normal implementation of the projects [4][5]. Review Procedures and Opinions - The company's board and supervisory committee have approved the proposal to use self-funds for the investment project, confirming that this action does not harm the interests of the company or its shareholders and complies with relevant regulations [5].

Core Viewpoint - Yifeng Pharmacy has extended the completion date of its fundraising project "Yifeng Digital Platform Upgrade Project" from July 31 to December 31, 2023, due to the complexity and challenges in integrating multiple systems [1] Group 1: Project Details - The implementation subject, method, total amount of raised funds, and usage remain unchanged despite the extension of the completion date [1] - The digital project involves integrating various systems including goods, logistics, finance, and human resources, which has led to delays in platform integration and promotion [1] Group 2: Challenges and Risks - The project faces challenges due to the strong interrelation of its components and the difficulty in collaboration, which has contributed to the delay [1] - Some hardware and software systems are deeply integrated with frontline business departments, necessitating thorough testing and feedback to avoid disconnects with actual business operations [1] - Certain remaining funds for personnel salaries, social insurance, and taxes cannot be paid directly from the fundraising account and need to be temporarily covered by the company's own funds, which will later be replaced by the raised funds [1] Group 3: Strategic Adjustments - The company aims to enhance the efficiency of fund usage and reduce investment risks by carefully evaluating the current progress of the fundraising project before deciding on the extension [1]

Group 1 - The core point of the article is that Yifeng Pharmacy announced an extension for the completion date of its fundraising investment project, specifically the "Yifeng Digital Platform Upgrade Project," to December 31, 2025 [1] Group 2 - The fifth board meeting and the thirteenth supervisory board meeting were held on July 30, 2025, to review and approve the proposal for the extension of the fundraising investment project [1]